Manhattan Scientifics, Inc. (OTCPK: MHTX)
Health Care · Biotechnology · US
$0.00
— today · 0.0% 1Y
Manhattan Scientifics, Inc. (OTCPK: MHTX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $559.00 and employs 1 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Manhattan Scientifics, Inc. across four factors: quality 9/100. Its strongest factor is quality.
MHTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $559.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 9.75
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 559.28M
- Employees
- 1
- Next earnings
- —
About Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. operates as an innovation hub, primarily dedicated to the advancement and market introduction of technologies designed to enhance human life across the United States. The company's specialized efforts are concentrated within the fields of nanotechnology and nanomedicine. Established in 1992 and headquartered in New York City, the firm was formerly known as Grand Enterprises, Inc.
- ISIN
- US5631221000
- Founded
- 1992
- Listed since
- Jan 6, 1998
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.09 | -0.01% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $65.40B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $59.75B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.